Market Focus Identify mid market R&D labs and CROs focused on oxidative stress and chronic inflammation that need biomarkers, assay kits, recombinant proteins, and antibodies to accelerate discovery.

Unique Offering Leverage CypExpress P450s expressed in a eukaryotic expression system with higher yields for metabolite profiling and scale-up, targeting drug metabolism groups seeking efficient, scalable liver enzyme resources over bacterial or microsomal options.

Cross Sell Portfolio Bundle GST isoforms, recombinant P450s, and antibody/kit offerings into integrated biomarker discovery workflows to upsell larger lab purchases and create end-to-end solutions for inflammation and oxidative stress research.

Size Advantage As a smaller biotech supplier with a nimble, relationship-driven sales model, OBR can pursue account-based selling to mid market labs and CROs, offering tailored kits, pricing, and quick support to build long term partnerships.

Growth Partnerships Position OBR as a specialist partner in oxidative stress and inflammation biomarker research and pharmacokinetics tools to differentiate from larger competitors; pursue distributor or collaboration partnerships to expand geographic reach and accelerate customer acquisition.